Decoding immunometabolism with next-generation tools: lessons from dendritic cells and T cells
Open Access
- 16 September 2025
- journal article
- review article
- Published by Springer Nature in The EMBO Journal
- Vol. 44 (21) , 5924-5939
Abstract
Cellular metabolism plays a pivotal role in regulating the effector functions and fate decisions of immune cells, shaping immune responses in homeostasis and disease. Metabolic pathways also serve as critical signaling hubs governing immune cell behavior. Deregulated metabolic pathways contribute to immune dysfunction, fueling disease progression and creating challenges for therapeutic interventions. The recent development of advanced technologies to delineate immunometabolic regulation has revolutionized our understanding of immune cell biology. These tools, ranging from quantitative single-cell metabolomics to in vivo spatial tissue profiling and DC-based metabolic therapy, have shifted the focus from broad nutrient pathways to a detailed exploration of metabolic reprogramming within disease microenvironments, revealing how metabolic changes drive immune cell activation, differentiation, and effector responses. The integration of immunometabolic insights into clinical practice holds strong potential for advancing precision medicine and developing targeted therapies that restore immune balance in pathological conditions. Here, we summarize emerging cutting-edge technologies related to immunometabolism and critically reflect on their current limitations. Finally, we discuss potential needs for developing novel methods that can uncover the intricate interplay between metabolism and immune cell function.Keywords
Funding Information
- Cancer Research Institute
- Swiss Caner foundation (KLS-5949-08-2023)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030_215126)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030L_208130)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (TMCF-3_213736)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (IZLCZ0_206083)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (CRSII5_205930)
- Helmut Horten Stifung
This publication has 122 references indexed in Scilit:
- Regulation and function of mTOR signalling in T cell fate decisionsNature Reviews Immunology, 2012
- HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cellsJournal of Experimental Medicine, 2011
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate CancerNew England Journal of Medicine, 2010
- Toll-like receptor–induced changes in glycolytic metabolism regulate dendritic cell activationBlood, 2010
- A Role for Lipid Bodies in the Cross-presentation of Phagocytosed Antigens by MHC Class I in Dendritic CellsImmunity, 2009
- The mTOR Kinase Differentially Regulates Effector and Regulatory T Cell Lineage CommitmentImmunity, 2009
- Lipid signalling in diseaseNature Reviews Molecular Cell Biology, 2008
- Flt3 Ligand Regulates Dendritic Cell Development from Flt3+ Lymphoid and Myeloid-committed Progenitors to Flt3+ Dendritic Cells In VivoJournal of Experimental Medicine, 2003
- Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activationProceedings of the National Academy of Sciences, 2002
- 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic dataXenobiotica, 1999